Pfizer Inc. is a world-leading biopharmaceutical company based on research and development of its own drugs. The company was established in 1849 with global headquarter in New York, USA.
Pfizer established its office in the Czech Republic in 1993. Today, with a market share of 5%, Pfizer is ranked among the top five largest pharmaceutical companies with a significant position on the Czech medical market.
Our business focuses on research, development and sales of medicines for human use, including biological drugs and vaccines. In addition, we offer a wide range of medical devices and consumer products. We also organize clinical trials, even in the Czech Republic.
Pfizer employs more than 97 000 employees worldwide and our drugs can be bought in more than 175 countries around the world. We produce medicinal products for more than 15 therapeutic areas. The most important therapeutic areas in the Czech Republic are oncology, rheumatology, cardiology, vaccines, central nervous system and women’s health.
In 2014, Pfizer founded the Global Financial Solutions (GFS) center in Prague - the fifth GFS center in the world, the second in Europe and the first in Central and Eastern Europe. The number of employees in this financial shared service center is constantly rising. Our goal is to reach the number of 200 financial specialists in the GFS center in Prague by the end of 2018, supporting markets of Central and Eastern Europe, Northern Africa and Middle East.